Principal Investigator(s):Hannah Kibuuka
Objective:Assess the safety, reactogenicity, and tolerability of the vaccination regimens.
Prevention Option(s):HIV Vaccine
Arms and Assigned Interventions
Mode of Delivery
Trial Sponsors: US Surgeon General/Dept. of the Army
June 30, 2015
Age range: 18 Years ↔ 40 Years